POLISCOPE
Back to feed
FEDERALhearing transcript
High Impact

Congressional Hearing on Organ Transplant System Reform

Original title: THE URGENT NEED TO REFORM THE ORGAN TRANSPLANTATION SYSTEM TO SECURE MORE ORGANS FOR WAITING, AILING, AND DYING PATIENTS

January 1, 2021

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

This hearing initiates a formal legislative review of the national organ procurement and transplantation network, which directly impacts the wait times and survival rates for thousands of patients currently on transplant waiting lists.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Patients on transplant waiting lists

These individuals are directly impacted by the efficiency and policies of the organ procurement system.

Organ Procurement Organizations

These organizations are responsible for the recovery of organs and are the subject of the proposed systemic reforms.

What changed

Last recorded activity January 1, 2021.

What's next

Next step not available in the current record.

Summary

The House Subcommittee on Economic and Consumer Policy held a hearing on May 4, 2021, to examine the effectiveness of the U.S. organ transplantation system. The session featured testimony from patients, medical professionals, and industry representatives regarding the need for systemic improvements to increase organ availability.

Key Facts

  • The hearing took place on May 4, 2021, via Zoom.
  • The hearing focused on the 'Urgent Need to Reform the Organ Transplantation System'.
  • Witnesses included patients waiting for transplants, a living donor, medical directors, and representatives from organ procurement organizations.
  • The subcommittee received testimony from two panels of experts and stakeholders.
  • Statements from the National Council on Disability and the American Society of Nephrology were entered into the record by unanimous consent.

Why It Matters

This hearing initiates a formal legislative review of the national organ procurement and transplantation network, which directly impacts the wait times and survival rates for thousands of patients currently on transplant waiting lists.

Frequently Asked Questions

What was the purpose of this hearing?
The hearing was held to investigate the current organ transplantation system in the U.S. and discuss potential reforms to increase the number of available organs for patients.
Who testified at the hearing?
The hearing featured two panels: the first included patients and a , and the second included medical directors and leaders of organ procurement organizations.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift80% confidence

Focus on OPO Accountability

The hearing signals a shift toward increased federal scrutiny of Organ Procurement Organizations to improve transplant outcomes.

Connected Entities

personRaja KrishnamoorthiChairman of the Subcommittee on Economic and Consumer PolicyMap →
personDr. Dara KassWitness, living donor, and mother of a transplant recipientMap →
personTonya IngramPatient witness waiting for an organ transplantMap →
organizationSubcommittee on Economic and Consumer PolicyCongressional body conducting the hearingMap →
organizationAssociation for Organ Procurement OrganizationsIndustry group represented by witnesses Steve Miller and Joe FerreiraMap →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment20
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record